Need a specific person's email?
Browse Medday Pharmaceuticals's employee directory (about 51 employees) and reveal verified emails free.
Medday Pharmaceuticals's most common email format is First.Last@medday-pharma.com (ex. John.Doe@medday-pharma.com), used for 80% of medday-pharma.com addresses. Medday Pharmaceuticals uses 4 email patterns.
| Format | Example | Share of medday-pharma.com |
|---|---|---|
| First.Last@medday-pharma.comMost common | John.Doe@medday-pharma.com | |
| Last@medday-pharma.com | Doe@medday-pharma.com | |
| FirstLast@medday-pharma.com | JohnDoe@medday-pharma.com | |
| First.MiddleLast@medday-pharma.com | John.MichaelDoe@medday-pharma.com |
Browse Medday Pharmaceuticals's employee directory (about 51 employees) and reveal verified emails free.
PharmaceuticalsÎle-de-France, France51-200 Employees
MedDay Pharmaceuticals is a mid-sized biopharmaceutical company based in Paris, France, focused on developing therapies for central nervous system disorders. Its clinical program has centered on progressive multiple sclerosis, with the investigational drug MD1003 advancing into Phase III testing. In 2017 the company broadened its research capabilities by acquiring Profilomic’s health division. In 2020, MD1003 failed to meet the primary and secondary endpoints in its second pivotal Phase III trial for progressive MS. MedDay operates in the pharmaceutical manufacturing sector, focusing on late-stage development for CNS disorders. Its activities include ongoing Phase III development for MD1003 in progressive MS.
Most common format
First.Last@medday-pharma.com
Example: John.Doe@medday-pharma.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.